Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Drug Makers, Institute Develop Longer-Lasting Cultured Cells

This article was originally published in PharmAsia News

Executive Summary

Several Japanese drug makers and Japan's National Institute of Health Sciences have developed a new technique for preserving cultured cells for drug compatibility evaluation. Researchers from Astellas Pharma, Chugai Pharmaceutical, Kyowa Hakko Kogyo, Mitsubishi Tanabe Pharma, Nippon Shinyaku and Sanofi-Aventis KK joined the institute in the development. The technique they came up with extends the effective life of enzymes used by cells to metabolize drugs, eliminating the need to prepare and maintain new cell cultures for drug development efforts. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts